Clinical and Molecular Characterization of Microphthalmia-associated Transcription Factor (MITF)-related Renal Cell Carcinoma

The mutational constraint spectrum quantified from variation in 141,456 humans

(2020) Konrad J. Karczewski et al.   NATURE

A comparison of outcomes for standard and multiplex partial nephrectomy in a solitary kidney: The National Cancer Institute experience

(2019) Joseph A. Baiocco et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Familial Kidney Cancer: Implications of New Syndromes and Molecular Insights

(2019) Maria I. Carlo et al.   EUROPEAN UROLOGY

The classification of pediatric and young adult renal cell carcinomas registered on the Children's Oncology Group (COG) protocol AREN03B2 after focused genetic testing

(2018) Mariana M. Cajaiba et al.   CANCER

Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma

(2018) Yuval Freifeld et al.   Current Urology Reports

Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276)

(2017) Youfeng Yang et al.   GENES CHROMOSOMES & CANCER

Analysis of protein-coding genetic variation in 60,706 humans

(2016) Monkol Lek et al.   NATURE

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

(2016)   NEW ENGLAND JOURNAL OF MEDICINE

The Microphthalmia-Associated Transcription Factor p.E318K Mutation Does Not Play a Major Role in Sporadic Renal Cell Tumors from Caucasian Patients

(2016) Christine G. Stoehr et al.   PATHOBIOLOGY

Prevalence ofMITFp.E318K in Patients With Melanoma Independent of the Presence ofCDKN2ACausative Mutations

(2016) Miriam Potrony et al.   JAMA Dermatology

MiT Family Translocation-Associated Renal Cell Carcinoma: A Contemporary Update With Emphasis on Morphologic, Immunophenotypic, and Molecular Mimics

(2015) Martin J. Magers et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Genomic Classification of Cutaneous Melanoma

(2015) Rehan Akbani et al.   CELL

EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB–Expressing Breast Cancer

(2015) Denise A. Yardley et al.   JOURNAL OF CLINICAL ONCOLOGY

Pro-Survival Role of MITF in Melanoma

(2015) Mariusz L. Hartman et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy

(2015) Claudia Wellbrock et al.   Pigment Cell & Melanoma Research

MiT family translocation renal cell carcinoma

(2015) Pedram Argani   SEMINARS IN DIAGNOSTIC PATHOLOGY

Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes

(2014) G. G. Malouf et al.   CLINICAL CANCER RESEARCH

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma

(2014) Patrick A. Ott et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Locally Advanced or Metastatic Breast Cancer

(2014) Johanna Bendell et al.   JOURNAL OF CLINICAL ONCOLOGY

Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

(2014) Steffen Durinck et al.   NATURE GENETICS

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers

(2014) Eric C. Kauffman et al.   Nature Reviews Urology

MITFE318K's effect on melanoma risk independent of, but modified by, other risk factors

(2014) Marianne Berwick et al.   Pigment Cell & Melanoma Research

The Nutrient-Responsive Transcription Factor TFE3 Promotes Autophagy, Lysosomal Biogenesis, and Clearance of Cellular Debris

(2014) J. A. Martina et al.   Science Signaling

A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma

(2013) M. N. Farley et al.   MOLECULAR CANCER RESEARCH

Comprehensive molecular characterization of clear cell renal cell carcinoma

(2013)   NATURE

Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics

(2012) W. M. Linehan   GENOME RESEARCH

Prevalence of the E318K MITF germline mutation in Italian melanoma patients: associations with histological subtypes and family cancer history

(2012) P. Ghiorzo et al.   Pigment Cell & Melanoma Research

Repeat partial nephrectomy

(2011) Brian Shuch et al.   CURRENT OPINION IN UROLOGY

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

(2011) Satoru Yokoyama et al.   NATURE

A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma

(2011) Corine Bertolotto et al.   NATURE

Inactivation of the FLCN Tumor Suppressor Gene Induces TFE3 Transcriptional Activity by Increasing Its Nuclear Localization

(2010) Seung-Beom Hong et al.   PLoS One

Gpnmbis a melanoblast-expressed, MITF-dependent gene

(2008) Stacie K. Loftus et al.   Pigment Cell & Melanoma Research